目的：观察唑来膦酸联合放疗治疗骨转移癌的疗效。
Objective:To evaluate the efficacy of zoledronic acid combined with radiotherapy for metastatic bone tumours.
目的：评价骨膦合并化疗治疗恶性肿瘤骨转移癌的疗效。
Furpose: Evaluated the curative effects of 11 cases bone metastases treated by bonefos combine chemotherapy.
目的： 对比观察骨转移癌疼痛行放疗止痛和博宁止痛的疗效。
Objective:To evaluate curative effect of bone metastatic cancer pain by radiotherapy and bonin.
目的探讨伊班膦酸钠（艾本）联合化疗治疗骨转移癌的临床疗效。
Objective To study the curative effect of ibandronate combined with chemotherapy in the treatment of metastatic bone cancer.
方法：98例骨转移癌患者随机分成观察组(51例)和对照组(47例)。
Methods: 98 patients with metastatic bone tumours were randomly divided into observation group (51 cases) and control group (47 cases).
目的探讨肢体骨转移癌患者行大段异体骨关节移植术及肢体功能康复方法并进行评价。
Objective To evaluate the operation of allografting for limb bone metastasis, and characterize the principles of surgical treatment.
结论：痛力克复合液对晚期癌痛病人的止痛安全有效，并对继发骨转移癌痛的病人效果更佳。
Conclusions:The later period cancer treatment with toradol was safe and effective, especially for patients with bone transform.
方法：在化疗间歇期应用伊班膦酸钠治疗骨转移癌患者68例，观察骨痛、活动能力、骨转移病灶、血钙变化及不良反应。
METHODS: All 68 patients were treated with ibandronate during the intermission of chemotherapy. Bone pain, ADL, bone metastasis focus, change of serum Ca2 + level and side effect were observed.
探讨SPECT骨显像对鼻咽癌颅底骨侵犯及全身骨转移早期检测的临床价值。
To investigate the early detecting value of SPECT in skull base bone invasion and bone metastases of nasopharyngeal carcinoma.
骨肉瘤的细胞学诊断与组织学对照符合率为93 4%，骨巨细胞瘤为87 5 %，骨转移性癌为91 6 %。
The diagnostic accuracy rates were 93 4% in osteosarcoma, 87 5% in bone giant cell tumor, 91 6% in bone metastatic carcinoma.
目的探讨宫颈癌放疗后骨转移的临床特点及其预后。
Objective To study the clinical features and prognosis of bone metastasis after radiotherapy for cervical cancer.
目的探讨宫颈癌放疗后骨转移的临床特点及其预后。
Objective To study the clinical features and prognosis of bone metastasis after radiotherapy for cervical cancer.
应用推荐